Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

C6orf167 Inhibitors

C6orf167 inhibitors pertain to a class of chemical compounds designed to interact with the protein encoded by the human gene C6orf167, also known as MICAL3 (molecule interacting with CasL protein 3). The name C6orf167 arises from its initial characterization as an open reading frame (ORF) on chromosome 6. The proteins in the MICAL family are known to be multi-domain flavoenzymes, which means they have the capacity to catalyze oxidation-reduction (redox) reactions using flavin adenine dinucleotide (FAD) as a cofactor. The precise biological function of C6orf167 is complex and multifaceted, involving the regulation of cytoskeletal dynamics. This includes its influence on actin filament disassembly and interactions with other proteins that are crucial for the maintenance of various cellular functions.

Inhibitors targeting C6orf167 are chemical agents that have been developed to specifically bind to this protein and modulate its activity. The design of such compounds typically stems from an understanding of the enzyme's structure and the key active sites that are essential for its enzymatic function. By binding to the MICAL3 protein, these inhibitors can affect the protein's ability to interact with its substrates or with other proteins within the cell. The development of inhibitors often involves the use of high-throughput screening techniques to identify potential molecules that demonstrate a high affinity for the target protein.

SEE ALSO...

Items 1 to 10 of 18 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Hydroxyurea can inhibit DNA synthesis and might potentially disrupt processes where C6orf167 plays a role in DNA repair.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

By inhibiting the DNA enzyme topoisomerase I, camptothecin may impact DNA dynamics and indirectly affect C6orf167 functionality.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide targets topoisomerase II. Altered DNA topology might interfere with the roles C6orf167 plays in DNA repair.

1-β-D-Arabinofuranosylcytosine

147-94-4sc-201628
sc-201628A
sc-201628B
sc-201628C
sc-201628D
1 g
5 g
25 g
100 g
250 g
$147.00
$258.00
$508.00
$717.00
$1432.00
1
(1)

1-β-D-Arabinofuranosylcytosine disrupts DNA synthesis. This disruption could indirectly influence processes where C6orf167 functions.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

Olaparib is a PARP inhibitor. While not directly targeting MMS22L, PARP inhibition can modulate DNA repair pathways in which C6orf167 might be involved.

Mitoxantrone

65271-80-9sc-207888
100 mg
$279.00
8
(1)

Mitoxantrone intercalates into DNA. This intercalation might indirectly alter processes where C6orf167 plays a role.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

By intercalating DNA and affecting topoisomerase II, doxorubicin could potentially influence C6orf167 functionality.

2′-Deoxy-2′,2′-difluorocytidine

95058-81-4sc-275523
sc-275523A
1 g
5 g
$56.00
$128.00
(1)

As a nucleoside analog, gemcitabine may interfere with DNA replication processes, potentially impacting C6orf167's roles.

Bleomycin Sulfate

9041-93-4sc-200134
sc-200134A
sc-200134B
sc-200134C
10 mg
50 mg
100 mg
500 mg
$206.00
$612.00
$1020.00
$2856.00
38
(3)

Bleomycin causes DNA breaks. Inducing such damage might overload or compete with the pathways C6orf167 is involved in.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$82.00
$300.00
$1082.00
30
(3)

Aphidicolin is a DNA polymerase inhibitor. It might indirectly impact C6orf167 functionality by stalling replication.